FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/01/079697 [Registered on: 29/01/2025] Trial Registered Prospectively
Last Modified On: 28/01/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Screening 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Aclinical trial to study effect of oral administration of indrayava yoga in patients with raktapradar  
Scientific Title of Study   Randomised open labelled control clinical study of efficacy of indrayava yoga in the management of raktapradar with special reference to menorrhagia  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Mayuri Manohar Kande 
Designation  Pg scholar  
Affiliation  MUHS  
Address  Siddhkala ayurved mahavidyalay hospital and reaserch center pimparne road sangamner Opd no 5 ground floor streerog prasuti tantra department 422605
Opd no 5 ground floor streerog and prasuti tantra department siddhkala ayurved mahavidyalay pimparne road sangamner
Ahmadnagar
MAHARASHTRA
422605
India 
Phone  8485807070  
Fax    
Email  mayurikande1998@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Rhuta N Saraf  
Designation  Associate professor  
Affiliation  MUHS 
Address  Siddhkala ayurved hospital and reaserch center pimparne road sangamner Opd no 5 ground floor streerog and prasuti tantra department 422605
Siddhkala ayurved mahavidyalay sangamner pimparne road sangamner
Ahmadnagar
MAHARASHTRA
422605
India 
Phone  8485807070  
Fax    
Email  rhutasaraf@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Mayuri Manohar Kande 
Designation  Pg scholar  
Affiliation  MUHS 
Address  Siddhkala ayurved mahavidyalay hospital and reaserch center pimparne road Opd no 5 ground floor streerog and prasuti tantra department 422605
Siddhkala ayurved mahavidyalay sangamner pimparne road sangamner 422605
Ahmadnagar
MAHARASHTRA
422605
India 
Phone  8485807070  
Fax    
Email  mayurikande1998@gmail.com  
 
Source of Monetary or Material Support  
siddhkala ayurved hospital and reaserch center pimparne road sangamner 422605 district ahemadnagar Maharashtra India  
 
Primary Sponsor  
Name  Dr Mayuri Manohar Kande  
Address  Siddhkala ayurvedic hospital and reaserch center pimparne road Opd no5 streerog and prasuti tantra department 422606 ahemadnagar 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mayuri manohar kande   Siddhkala ayurved hoapital pimparne road sangamner 422605  siddhkala ayurvedic hospital and reaserch center ground floor opd no. 5 streerog and prasuti tantra department pimparne road sangamner 422605
Ahmadnagar
MAHARASHTRA 
8485807070

mayurikande1998@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
siddhkala ayurved medical college post graduate and reaserch center sangamner institutional ethical committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N920||Excessive and frequent menstruation with regular cycle. Ayurveda Condition: ARTAVAVRUDDHIH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Tab pause 500mg Tablet pause 500mg bd for 5 days from day 3rdto 7th day of menstrual cycle
2Intervention ArmDrugClassical(1) Medicine Name: Indrayava granules , Reference: Bhaishajya ratnavali pradar rog chikitsa , Route: Oral, Dosage Form: Khanda /Granules, Dose: 6(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: Koshnajala), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  Age 18-45 patients with sign and symptoms of raktapradara excessive bleeding per vaginal for consecutive 3 menstrual cycles HB More than 8gm% 
 
ExclusionCriteria 
Details  Age less than 18 and more than 45 pt with blood dyacariasis,hb less than 8gm% pt with iucd ,pt with major systemic disorders like HTN ,DM,TB ,hiv, hbsag  
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To reduce the rajastrava praman
Amount of blood loss by PBAC chart
Adhodar shoola
Rajastrav kalavadhi
Improve swaroop of rajastrava  
At the 4th week 8th week and final outcome after 12 weeks after interventional drug use  
 
Secondary Outcome  
Outcome  TimePoints 
To access effect of interventional drugs effect on sign & symptoms & its longitivity   To access results on 8th week & 12th week  
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   10/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response (Others) -  nil

  6. For how long will this data be available start date provided 02-01-1970 and end date provided 02-01-1970?
    Response (Others) -  nil

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - nil
Brief Summary   60 patient taken for study in two groups of 30_30 each one gropu will be trial in which indrayava churna with sita granules given before meal with warm water in the management of raktapradar and another group with tablet pause 500mg given for 5 days of menses  effect and comparison of effect will be seen in both groups and results will be observed  
Close